19-46746249-T-G
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_013403.3(STRN4):c.182A>C(p.Glu61Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_013403.3 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive limb-girdle muscular dystrophy type 2IInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, G2P, Ambry Genetics
- muscular dystrophy-dystroglycanopathy type B5Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae)
- myopathy caused by variation in FKRPInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- congenital muscular dystrophy with cerebellar involvementInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- congenital muscular dystrophy with intellectual disabilityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- congenital muscular dystrophy without intellectual disabilityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- muscle-eye-brain diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STRN4 | NM_013403.3 | c.182A>C | p.Glu61Ala | missense_variant | Exon 1 of 18 | ENST00000263280.11 | NP_037535.2 | |
FKRP | NM_024301.5 | c.-253+159T>G | intron_variant | Intron 1 of 3 | ENST00000318584.10 | NP_077277.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STRN4 | ENST00000263280.11 | c.182A>C | p.Glu61Ala | missense_variant | Exon 1 of 18 | 1 | NM_013403.3 | ENSP00000263280.4 | ||
FKRP | ENST00000318584.10 | c.-253+159T>G | intron_variant | Intron 1 of 3 | 1 | NM_024301.5 | ENSP00000326570.4 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 1344790Hom.: 0 Cov.: 35 AF XY: 0.00 AC XY: 0AN XY: 666298
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.182A>C (p.E61A) alteration is located in exon 1 (coding exon 1) of the STRN4 gene. This alteration results from a A to C substitution at nucleotide position 182, causing the glutamic acid (E) at amino acid position 61 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at